Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment 5. Debunking Myths in the US Healthcare System
Top Ten Searches
aldosteronism contrast dialysis vitamin d bicarbonate arf amyloidosis hypocalcemia renal artery husYour Article Summary
See Latest ArticlesT Cell–Based Immunotherapy of Metastatic Renal Cell Carcinoma: Modest Success and Future Perspective
Clinical Cancer Research, 10/26/09
Shablak A et al. – The growing evidence of success by combining expanded tumor–infiltrating lymphocytes with lymphodepletion merits investigation in MRCC. Identifying new RCC–associated antigens, optimized methods, and conditions for detection, isolation, and/or modification and expansion of tumor–specific T cells are all important strategies to be pursued for improving T cell–based immunotherapy of MRCC.
Today in Hematology/Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Upfront, randomized, phase II trial of sorafenib versus sorafenib and low-dose interferon alfa in patients with advanced renal cell carcinoma
Cancer, 11/03/09
A Randomized Controlled Study of Weekly and Biweekly Dosing of Epoetin Alfa in CKD Patients With Anemia
Clinical Journal of the American Society of Nephrology, 11/05/09
Anemia and Erythrocytosis After Kidney Transplantation: A 5-Year Graft Function and Survival Analysis
Transplantation Proceedings, 11/11/09
Article Search
Sponsor